{"id":16951,"date":"2021-03-11T14:27:03","date_gmt":"2021-03-11T13:27:03","guid":{"rendered":"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/"},"modified":"2021-03-11T14:34:48","modified_gmt":"2021-03-11T13:34:48","slug":"new-viasure-test-identifies-the-sars-cov-2-uk-variant","status":"publish","type":"post","link":"https:\/\/www.certest.es\/es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/","title":{"rendered":"Nuevo test VIASURE que identifica la variante inglesa del SARS-CoV-2"},"content":{"rendered":"<p>El 14 de diciembre de 2020, Reino Unido declar\u00f3 un aumento en la incidencia del SARS-CoV-2 en algunas regiones de su pa\u00eds asociado a una nueva variante del virus con una supuesta mayor capacidad de transmisi\u00f3n. Esta variante, denominada VOC202012 \/ 01 (B.1.1.7) present\u00f3 23 mutaciones diferentes: 13 no sin\u00f3nimas, incluyendo una serie de mutaciones en la prote\u00edna spike (S), 4 deleciones y 6 sin\u00f3nimas. A finales de diciembre, esta variante se hab\u00eda detectado en 31 pa\u00edses, y en 5 de las 6 regiones de la OMS. Una de estas mutaciones es la deleci\u00f3n en las posiciones 69-70 de la prote\u00edna spike. La detecci\u00f3n de la deleci\u00f3n HV 69\/70 es de vital importancia ya que se ha relacionado con la p\u00e9rdida de inmunidad en pacientes inmunosuprimidos y con una mayor infectividad viral.<\/p>\n<p><img decoding=\"async\" class=\"alignnone wp-image-16946 size-full\" src=\"https:\/\/www.certest.es\/wp-content\/uploads\/2021\/03\/Plantilla_foto_interior_noticia.jpg\" alt=\"\" width=\"600\" height=\"263\" srcset=\"https:\/\/www.certest.es\/wp-content\/uploads\/2021\/03\/Plantilla_foto_interior_noticia-200x88.jpg 200w, https:\/\/www.certest.es\/wp-content\/uploads\/2021\/03\/Plantilla_foto_interior_noticia-300x132.jpg 300w, https:\/\/www.certest.es\/wp-content\/uploads\/2021\/03\/Plantilla_foto_interior_noticia-400x175.jpg 400w, https:\/\/www.certest.es\/wp-content\/uploads\/2021\/03\/Plantilla_foto_interior_noticia.jpg 600w\" sizes=\"(max-width: 600px) 100vw, 600px\" \/><\/p>\n<p><strong>VIASURE <em>SARS-CoV-2 &amp; UK Variant (S UK, ORF1ab and N genes) <\/em>Real Time PCR Detection Kit es una prueba de RT-PCR en tiempo real dise\u00f1ada para la detecci\u00f3n cualitativa de RNA de SARS-COV-2 y de la deleci\u00f3n HV 69\/70 del gen <em>S <\/em>para el SARS-CoV-2 asociada a la variante SARS-CoV-2 VOC-202012\/01 (linaje B.1.1.7) y a otras variantes, en frotis nasofar\u00edngeo procedente de individuos con sospecha de COVID-19 por su profesional de la salud.<\/strong><\/p>\n<p>Una preocupaci\u00f3n con respecto a las nuevas variantes es que su detecci\u00f3n por t\u00e9cnicas moleculares (RT-PCR) puede verse afectada. Por esta raz\u00f3n, <strong>la mayor\u00eda de las pruebas de PCR comerciales utilizan m\u00faltiples dianas ubicadas en diferentes genes del SARS-CoV-2, por lo que la probabilidad de que no se detecten nuevas variantes disminuye.<\/strong><\/p>\n<p>M\u00e1s informaci\u00f3n: <a href=\"https:\/\/www.certest.es\/es\/products\/sars-cov-2-uk-variant-s-uk-orf1ab-and-n-genes\/\" target=\"_blank\" rel=\"noopener noreferrer\">SARS-CoV-2 &amp; UK Variant (S UK, ORF1ab and N genes)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El 14 de diciembre de 2020, Reino Unido declar\u00f3 un  [&#8230;]<\/p>\n","protected":false},"author":1,"featured_media":16949,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1268,23,1],"tags":[112,113,291,948,136,253,189,952,140],"class_list":["post-16951","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-covid-19-es","category-destacadas","category-noticias","tag-biotec","tag-certest","tag-coronavirus","tag-covid-19-es","tag-detection","tag-diagnosis","tag-pcr","tag-sars-cov-2-es","tag-viasure"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nuevo test VIASURE que identifica la variante inglesa del SARS-CoV-2 - Certest Biotec - Raw Materials | Diagnostics | Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nuevo test VIASURE que identifica la variante inglesa del SARS-CoV-2 - Certest Biotec - Raw Materials | Diagnostics | Pharma\" \/>\n<meta property=\"og:description\" content=\"El 14 de diciembre de 2020, Reino Unido declar\u00f3 un [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/\" \/>\n<meta property=\"og:site_name\" content=\"Certest Biotec - Raw Materials | Diagnostics | Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-11T13:27:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-11T13:34:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.certest.es\/wp-content\/uploads\/2021\/03\/Plantilla_portada_noticias.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"403\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Certest\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Certest\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/\",\"url\":\"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/\",\"name\":\"Nuevo test VIASURE que identifica la variante inglesa del SARS-CoV-2 - Certest Biotec - Raw Materials | Diagnostics | Pharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.certest.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.certest.es\/wp-content\/uploads\/2021\/03\/Plantilla_portada_noticias.jpg\",\"datePublished\":\"2021-03-11T13:27:03+00:00\",\"dateModified\":\"2021-03-11T13:34:48+00:00\",\"author\":{\"@id\":\"https:\/\/www.certest.es\/#\/schema\/person\/608858cdd4fe7a40dce9e54dfa68dc34\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/#primaryimage\",\"url\":\"https:\/\/www.certest.es\/wp-content\/uploads\/2021\/03\/Plantilla_portada_noticias.jpg\",\"contentUrl\":\"https:\/\/www.certest.es\/wp-content\/uploads\/2021\/03\/Plantilla_portada_noticias.jpg\",\"width\":700,\"height\":403},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.certest.es\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nuevo test VIASURE que identifica la variante inglesa del SARS-CoV-2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.certest.es\/#website\",\"url\":\"https:\/\/www.certest.es\/\",\"name\":\"Certest Biotec - Raw Materials | Diagnostics | Pharma\",\"description\":\"Productos para diagn\u00f3stico in vitro\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.certest.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.certest.es\/#\/schema\/person\/608858cdd4fe7a40dce9e54dfa68dc34\",\"name\":\"Certest\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nuevo test VIASURE que identifica la variante inglesa del SARS-CoV-2 - Certest Biotec - Raw Materials | Diagnostics | Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/","og_locale":"es_ES","og_type":"article","og_title":"Nuevo test VIASURE que identifica la variante inglesa del SARS-CoV-2 - Certest Biotec - Raw Materials | Diagnostics | Pharma","og_description":"El 14 de diciembre de 2020, Reino Unido declar\u00f3 un [...]","og_url":"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/","og_site_name":"Certest Biotec - Raw Materials | Diagnostics | Pharma","article_published_time":"2021-03-11T13:27:03+00:00","article_modified_time":"2021-03-11T13:34:48+00:00","og_image":[{"width":700,"height":403,"url":"https:\/\/www.certest.es\/wp-content\/uploads\/2021\/03\/Plantilla_portada_noticias.jpg","type":"image\/jpeg"}],"author":"Certest","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Certest","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/","url":"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/","name":"Nuevo test VIASURE que identifica la variante inglesa del SARS-CoV-2 - Certest Biotec - Raw Materials | Diagnostics | Pharma","isPartOf":{"@id":"https:\/\/www.certest.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/#primaryimage"},"image":{"@id":"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/#primaryimage"},"thumbnailUrl":"https:\/\/www.certest.es\/wp-content\/uploads\/2021\/03\/Plantilla_portada_noticias.jpg","datePublished":"2021-03-11T13:27:03+00:00","dateModified":"2021-03-11T13:34:48+00:00","author":{"@id":"https:\/\/www.certest.es\/#\/schema\/person\/608858cdd4fe7a40dce9e54dfa68dc34"},"breadcrumb":{"@id":"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/#primaryimage","url":"https:\/\/www.certest.es\/wp-content\/uploads\/2021\/03\/Plantilla_portada_noticias.jpg","contentUrl":"https:\/\/www.certest.es\/wp-content\/uploads\/2021\/03\/Plantilla_portada_noticias.jpg","width":700,"height":403},{"@type":"BreadcrumbList","@id":"https:\/\/www.certest.es\/news\/new-viasure-test-identifies-the-sars-cov-2-uk-variant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.certest.es\/es\/"},{"@type":"ListItem","position":2,"name":"Nuevo test VIASURE que identifica la variante inglesa del SARS-CoV-2"}]},{"@type":"WebSite","@id":"https:\/\/www.certest.es\/#website","url":"https:\/\/www.certest.es\/","name":"Certest Biotec - Raw Materials | Diagnostics | Pharma","description":"Productos para diagn\u00f3stico in vitro","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.certest.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.certest.es\/#\/schema\/person\/608858cdd4fe7a40dce9e54dfa68dc34","name":"Certest"}]}},"_links":{"self":[{"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/posts\/16951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/comments?post=16951"}],"version-history":[{"count":0,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/posts\/16951\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/media\/16949"}],"wp:attachment":[{"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/media?parent=16951"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/categories?post=16951"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.certest.es\/es\/wp-json\/wp\/v2\/tags?post=16951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}